Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.

@article{Levegrn2002RiskGD,
  title={Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer.},
  author={S. Levegr{\"u}n and Andrew Jackson and Michael J Zelefsky and Ennapadam S Venkatraman and Mark W. Skwarchuk and Wolfgang Schlegel and Zvi Y Fuks and Steven A. Leibel and C. Clifton Ling},
  journal={Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology},
  year={2002},
  volume={63 1},
  pages={11-26}
}
BACKGROUND AND PURPOSE We fit phenomenological tumor control probability (TCP) models to biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer patients to quantify the local dose-response of prostate cancer. MATERIALS AND METHODS We analyzed the outcome after photon beam 3D-CRT of 103 patients with stage T1c-T3 prostate cancer treated at Memorial Sloan-Kettering Cancer Center (MSKCC) (prescribed target doses between 64.8 and 81Gy) who had a prostate… CONTINUE READING